The "2019 Korea Enterprise AwardsCeremony" hosted by MoneyToday(MT) was held at the Press Center inJung-gu, Seoul on the afternoon of the 27th. At the event, Aestura (CEO Un-seopLim) won the "Quality Award" and Olive Healthcare (CEO Sung-ho Han)won the "Health Care Award." Quratis (CEO Kwan-koo Cho) and MedicareGroup(CEO Do-hyun Na) were awarded the "Bio Grand Award."

Quratis is a new drug development company such astuberculosis vaccines for teenagers and adults. Currently, Quratis have beenconducting clinical trials phase 2a (adult) and phase 1 (youth) in South Koreato develop tuberculosis vaccines. 

After clinical trials in South Korea, thecompany plans to conduct global clinical trials in five Asian countries. In May(2019), Quratis also began to build manufacturing facilities in O-song, ChungcheongProvince that meet the requirements of CGMP (US Food and DrugAdministration-recognized production standards), EU GMP (European Medicines Manufacturing Standards), and KGMP (Korean Good Manufacturing Practice)."We will make efforts to self-sufficiency of tuberculosis vaccines in SouthKorea," the company said. "As a hub of global vaccines, we willstrive to become a unicorn company."